Ibere Pharmaceuticals reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net income was USD 1.47 million compared to net loss of USD 0.112267 million a year ago.
For the six months, net income was USD 5.05 million compared to net loss of USD 0.517965 million a year ago.